Clinical Trial Update: A Study of Oral Methylnaltrexone (MNTX) for the Treatment of Opioid-Induced Constipation (OIC) in Participants With Chronic, Non-Malignant Pain [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating oral methylnaltrexone (MNTX) for treating opioid-induced constipation in adults with chronic non-malignant pain has completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-malignant Pain
• Opioid-induced Constipation

Drugs mentioned

• Methylnaltrexone (methylnaltrexone)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Opioid-Induced Constipation | Phase 3 | Status: COMPLETED | Results posted: 2019-09-06